Combined with the results that the serum CXCL10 levels were significantly elevated in overweight patients with MDD and were positively correlated with BMI in patients with MDD in the present study, these findings provide more data linking peripheral CXCL10 to the obesity status in patients with MDD. This evidence concerns the gene CXCL10 and obesity due to melanocortin 4 receptor deficiency.